A citation-based method for searching scientific literature

R C Smedley, J Lamoureux, D G Sledge, M Kiupel. Vet Pathol 2011
Times Cited: 54







List of co-cited articles
385 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases.
J A Ramos-Vara, M E Beissenherz, M A Miller, G C Johnson, L W Pace, A Fard, S J Kottler. Vet Pathol 2000
171
35

Prognostic markers for canine melanocytic neoplasms: a comparative review of the literature and goals for future investigation.
R C Smedley, W L Spangler, D G Esplin, B E Kitchell, P J Bergman, H-Y Ho, I L Bergin, M Kiupel. Vet Pathol 2011
118
31

A comparative review of melanocytic neoplasms.
S H Smith, M H Goldschmidt, P M McManus. Vet Pathol 2002
224
27

Prognostic evaluation of Ki67 threshold value in canine oral melanoma.
I L Bergin, R C Smedley, D G Esplin, W L Spangler, M Kiupel. Vet Pathol 2011
74
24




Canine oral melanoma.
Philip J Bergman. Clin Tech Small Anim Pract 2007
117
18

Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.
Philip J Bergman, Joanne McKnight, Andrew Novosad, Sarah Charney, John Farrelly, Diane Craft, Michelle Wulderk, Yusuf Jeffers, Michel Sadelain, Ann E Hohenhaus,[...]. Clin Cancer Res 2003
230
18

Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor.
Deborah A Grosenbaugh, A Timothy Leard, Philip J Bergman, Mary K Klein, Karri Meleo, Steven Susaneck, Paul R Hess, Monika K Jankowski, Pamela D Jones, Nicole F Leibman,[...]. Am J Vet Res 2011
129
18

A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma.
J M Ottnod, R C Smedley, R Walshaw, J G Hauptman, M Kiupel, J E Obradovich. Vet Comp Oncol 2013
73
16

Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma.
R Mark Simpson, Boris C Bastian, Helen T Michael, Joshua D Webster, Manju L Prasad, Catherine M Conway, Victor M Prieto, Joy M Gary, Michael H Goldschmidt, D Glen Esplin,[...]. Pigment Cell Melanoma Res 2014
91
16

MIB-1 immunoreactivity correlates with biologic behaviour in canine cutaneous melanoma.
C Laprie, J Abadie, M F Amardeilh, J L Net, M Lagadic, M Delverdier. Vet Dermatol 2001
36
22

Immunohistochemical characteristics of melanoma.
Steven J Ohsie, G Peter Sarantopoulos, Alistair J Cochran, Scott W Binder. J Cutan Pathol 2008
327
14

Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.
P J Bergman, M A Camps-Palau, J A McKnight, N F Leibman, D M Craft, C Leung, J Liao, I Riviere, M Sadelain, A E Hohenhaus,[...]. Vaccine 2006
164
12

Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
A Murakami, T Mori, H Sakai, M Murakami, T Yanai, Y Hoshino, K Maruo. Vet Comp Oncol 2011
34
20

Naturally occurring melanomas in dogs as models for non-UV pathways of human melanomas.
Marc Gillard, Edouard Cadieu, Clotilde De Brito, Jérôme Abadie, Béatrice Vergier, Patrick Devauchelle, Frédérique Degorce, Stephane Dréano, Aline Primot, Laetitia Dorso,[...]. Pigment Cell Melanoma Res 2014
85
12

Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
E G MacEwen, I D Kurzman, D M Vail, R R Dubielzig, K Everlith, B R Madewell, C O Rodriguez, B Phillips, C H Zwahlen, J Obradovich,[...]. Clin Cancer Res 1999
76
11

A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation.
David R Proulx, David M Ruslander, Richard K Dodge, Marlene L Hauck, Laurel E Williams, Birgitte Horn, G Sylvester Price, Donald E Thrall. Vet Radiol Ultrasound 2003
95
11

Immunohistochemical investigation of PNL2 reactivity of canine melanocytic neoplasms and comparison with Melan A.
Chiara Giudice, Fabrizio Ceciliani, Marco Rondena, Damiano Stefanello, Valeria Grieco. J Vet Diagn Invest 2010
21
28


Canine oral melanoma: comparison of surgery versus surgery plus Corynebacterium parvum.
E G MacEwen, A K Patnaik, H J Harvey, A A Hayes, R Matus. Cancer Invest 1986
91
11

KIT gene exon 11 mutations in canine malignant melanoma.
Pei-Yi Chu, Siou-Li Pan, Chen-Hsuan Liu, Jihjong Lee, Lih-Seng Yeh, Albert T Liao. Vet J 2013
27
22

CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA.
Federica Riccardo, Selina Iussich, Lorella Maniscalco, Saray Lorda Mayayo, Giuseppe La Rosa, Maddalena Arigoni, Raffaella De Maria, Francesca Gattino, Stefania Lanzardo, Elena Lardone,[...]. Clin Cancer Res 2014
45
13




COX-1 and COX-2 expression in canine cutaneous, oral and ocular melanocytic tumours.
I Pires, A Garcia, J Prada, F L Queiroga. J Comp Pathol 2010
29
17

Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B-cell lymphoma.
Alessandra Gavazza, George Lubas, Arthur Fridman, Daniela Peruzzi, Joseph A Impellizeri, Laura Luberto, Emanuele Marra, Giuseppe Roscilli, Gennaro Ciliberto, Luigi Aurisicchio. Hum Gene Ther 2013
30
16

Randomized, placebo-controlled, double-blinded chemoimmunotherapy clinical trial in a pet dog model of diffuse large B-cell lymphoma.
Laura Marconato, Patrick Frayssinet, Nicole Rouquet, Stefano Comazzi, Vito Ferdinando Leone, Paola Laganga, Federica Rossi, Massimo Vignoli, Lorenzo Pezzoli, Luca Aresu. Clin Cancer Res 2014
51
9

Electro-gene-transfer as a new tool for cancer immunotherapy in animals.
J A Impellizeri, G Ciliberto, L Aurisicchio. Vet Comp Oncol 2014
16
31

Translation of new cancer treatments from pet dogs to humans.
Melissa Paoloni, Chand Khanna. Nat Rev Cancer 2008
435
9

Xenogeneic murine tyrosinase DNA vaccine for malignant melanoma of the digit of dogs.
C A Manley, N F Leibman, J D Wolchok, I C Rivière, S Bartido, D M Craft, P J Bergman. J Vet Intern Med 2011
37
13

Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma.
A N Alexander, M K Huelsmeyer, Ann Mitzey, R R Dubielzig, I D Kurzman, E G Macewen, D M Vail. Cancer Immunol Immunother 2006
53
9

Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2.
F Quintin-Colonna, P Devauchelle, D Fradelizi, B Mourot, T Faure, P Kourilsky, C Roth, M Mehtali. Gene Ther 1996
55
9

Bone marrow-derived dendritic cell vaccination of dogs with naturally occurring melanoma by using human gp100 antigen.
Steve Gyorffy, Juan Carlos Rodriguez-Lecompte, J Paul Woods, Ronan Foley, Stephen Kruth, Patricia C Y Liaw, Jack Gauldie. J Vet Intern Med 2005
37
13


S-100 immunoreactivity in melanomas of two marsupials, a bird, and a reptile.
D F Kusewitt, R L Reece, K B Miska. Vet Pathol 1997
23
21


Mitotic Count and the Field of View Area: Time to Standardize.
D J Meuten, F M Moore, J W George. Vet Pathol 2016
101
9

Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK.
S Verganti, D Berlato, L Blackwood, I Amores-Fuster, G A Polton, R Elders, R Doyle, A Taylor, S Murphy. J Small Anim Pract 2017
28
17


Immunohistochemical characterization and evaluation of prognostic factors in canine oral melanomas with osteocartilaginous differentiation.
J Sánchez, G A Ramirez, A J Buendia, M Vilafranca, C M Martinez, J Altimira, J A Navarro. Vet Pathol 2007
18
22



Uveal spindle cell tumor of blue-eyed dogs: an immunohistochemical study.
M K Zarfoss, G Klauss, K Newkirk, M Kiupel, Y Jones, C M H Colitz, R R Dubielzig. Vet Pathol 2007
20
20

Evaluation of tyrosinase expression in canine and equine melanocytic tumors.
Jeffrey C Phillips, Luis M Lembcke, Christina E Noltenius, Shelley J Newman, James T Blackford, Deborah A Grosenbaugh, A Timothy Leard. Am J Vet Res 2012
15
26

Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma.
Saray Lorda Mayayo, Simone Prestigio, Lorella Maniscalco, Giuseppe La Rosa, Arianna Aricò, Raffaella De Maria, Federica Cavallo, Soldano Ferrone, Paolo Buracco, Selina Iussich. Vet J 2011
29
13


Exon 15 BRAF mutations are uncommon in canine oral malignant melanomas.
Suzanne Shelly, May B Chien, Becky Yip, Michael S Kent, Alain P Theon, Jennifer L McCallan, Cheryl A London. Mamm Genome 2005
32
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.